Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643175 · ClinicalTrials.gov registry record
Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 20
- Enrollment target
NCT00643175 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 20 participants.
The verdict
NCT00643175 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studies have shown that prior fracture increases the risk for further fracture. In 2004 the Surgeon General released a report on osteoporosis, the details of which include multi-disciplinary treatment of osteoporotic fractures. Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Possible planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.
Interventions
- BEHAVIORAL Automated follow up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00643175
The ClinicalTrials.gov registry entry for NCT00643175 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated follow up is the first listed.
NCT00643175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00643175 about?
NCT00643175 is a clinical study titled "Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture". Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studi...
What is the current status of trial NCT00643175?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2007-06. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00643175?
The interventions under investigation include: Automated follow up (BEHAVIORAL).
Who is sponsoring clinical trial NCT00643175?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.